Stability of cefoselis sulfate in aqueous solutions
Tóm tắt
The influence of pH on the stability of cefoselis sulfate was investigated in the pH range 0.44–13.00. The degradation of cefoselis sulfate in aqueous solutions was a pseudo-first order reaction. General acid–base hydrolysis of cefoselis sulfate was observed in phosphate and acetate buffers. In solutions of hydrochloric acid, sodium hydroxide and borate buffer, kobs = kpH because only specific acid–base catalysis occurred. Specific acid–base catalysis of cefoselis sulfate involved such reactions as the hydrolysis of protonated cefoselis sulfate molecules (k1), hydrolysis of cefoselis sulfate zwitter ions (k2) and hydrolysis of cefoselis sulfate monoanions (k3) under the influence of water. The total reaction rate was equal to the sum of partial reactions: kpH = k1·F1 + k2·F2 + k3·F3 where: k1, k2 and k3 were the catalytic rate constants calculated as the mean values of kpH at pH 1.89–3.10, 4.01–6.16 and at pH above 11.24. F1, F2 and F3 were the molar concentration fractions of the cefoselis sulfate.
Tài liệu tham khảo
Akaho E, Nakayama H (2003) J Antibiot (Tokyo) 56(4):379–391
Flessner T, Jautelat R, Scholz U, Winterfeldt E (2004) Fortschr Chem Org Naturst 87:1–80
Hwu JR, Ethiraj KS, Hakimelahi GH (2003) Mini Rev Med Chem 3(4):305–313
Patel G, Rajput S (2011) Acta Chromatogr 23(2):215–234
Ikeda Y, Ban J, Ishikawa T, Hashiguchi S, Urayama S, Horibe H (2008) Chem Pharm Bull 56(10):1406–1411
Jelińska A, Dobrowolski L, Oszczapowicz I (2004) J Pharm Biomed Anal 35(5):1273–1277
Sugioka T, Asano T, Chikaraishi Y, Suzuki E, Sano A, Kuriki T, Shirotsuka M, Saito K (1990) Chem Pharm Bull 38(7):1998–2002
Fubara JO, Notari RE (1998) J Pharm Sci 87(12):1572–1576
Medenecka B, Jelińska A, Zając M, Bałdyka M, Juszkiewicz K, Oszczapowicz II (2009) Acta Pol Pharm 66(5):563–569
Jelińska A, Medenecka B, Zając M, Knajsiak M (2008) Acta Pol Pharm 65(2):261–265
Zając M, Jelińska A, Zalewski P (2005) Acta Pol Pharm 62(2):89–94
Jelińska A, Dudzińska I, Zając M, Oszczapowicz I, Krzewski W (2005) Acta Pol Pharm 62(3):183–187
Zając M, Jelińska A, Dobrowolski L, Oszczapowicz I (2003) J Pharm Biomed Anal 32(6):1181–1187
Jelińska A, Zając M, Gostomska J, Szczepaniak M (2003) Farmaco 58(4):309–313
Jelińska A, Zając M, Jakubowska M (2001) React Kinet Catal Lett 73(2):325–331
Kuriyama T, Karasawa T, Nakagawa K, Nakamura S, Yamamoto E (2002) Oral Microbiol Immunol 17(5):285–289
Climo MW, Markowitz SM, Williams DS, Hale-Cooper CG, Archer GL (1997) J Antimicrob Chemother 40(1):59–66
Zalewski P, Cielecka-Piontek J (2011) Ann Acad Med Siles 65(3):77–81
Zalewski P, Cielecka-Piontek J, Jelińska A (2012) Cent Eur J Chem 10(1):121–126
Pawełczyk E, Hermann T (1982) The fundamentals of stability drugs (Poland). PZWL, Warsaw